Share
Journal Information
Most Often Read
630
Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review articleMohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio
630
Open access
593
Liquid biopsy in chronic liver diseaseHugo A. Barrera-Saldaña, Luis E. Fernández-Garza, Silvia A. Barrera-Barrera
Ann Hepatol. 2021;20C:197
593
Open access
559
Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antiviralsDimitrios N. Samonakis, Maria Psyllaki, Konstantia I. Pavlaki, Elias Drakos, Elias Kehagias, Maria Tzardi, Helen A. Papadaki
Ann Hepatol. 2021;21C:141
559
Open access
430
Liver transplantation in acute liver failure due to Hepatitis B. Two clinical casesRocío Sedano, Lorena Castro, Mauricio Venegas, Julio Miranda, Carmen Hurtado, Jaime Poniachik, Javier Brahm
Ann Hepatol. 2021;21C:107
430
Open access
403
STAT3: A key regulator in liver fibrosisJie Zhao, Yong-Fen Qi, Yan-Rong Yu
Ann Hepatol. 2021;21C:224
403
Open access
386
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplantIlaria Lenci, Benedetto Neri, Daniele Morosetti, Martina Milana, Giampiero Palmieri, Giuseppe Tisone, Antonio Orlacchio, Mario Angelico, Leonardo Baiocchi
386
Open access
284
Sinusoidal obstruction syndrome secondary the intake of Senecio brasiliensis: A case reportSamantha Thifani Alrutz Barcelos, Vincent Marin Dall’Oglio, Alexandre de Araújo, Carlos Thadeu Schmidt Cerski, Mário Reis Álvares-da-Silva
Ann Hepatol. 2021;20C:138
284
Open access
280
Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosisSahaj Rathi, Trana Hussaini, Eric M. Yoshida
Ann Hepatol. 2021;20C:211
280
Open access
268
Hepatocellular carcinoma treatment with Sorafenib: A remarkable case of eight-years remission without significant toxicityAna L. Santos, Hélder Cardoso, Marco Silva, Adriana Moreira, Guilherme Macedo
Ann Hepatol. 2021;21C:116
268
Open access
255
An Integrated Review of the Hepatorenal SyndromeAlicia S. Ojeda-Yuren, Eira Cerda-Reyes, Maria R. Herrero-Maceda, Graciela Castro-Narro, Salvatore Piano
255
Open access
232
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)Ivan Lopez-Mendez, Jorge Aquino-Matus, Sofia Murua-Beltrán Gall, Jose D. Prieto-Nava, Eva Juarez-Hernandez, Misael Uribe, Graciela Castro-Narro
Ann Hepatol. 2021;20C:271
232
Open access
Open Article
230
The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studiesUmar Hayat, Ali A. Siddiqui, Hayrettin Okut, Saba Afroz, Syed Tasleem, Ahmed Haris
Ann Hepatol. 2021;20C:254
230
Open access
224
Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the diseaseGuillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Norberto Carlos Chávez-Tapia, Natalia Nuño-Lámbarri
Ann Hepatol. 2021;21C:212
224
Open access
219
Preserving the organ donor pool and suprahepatic vena cava: Case series of transverse hepatectomy for polycystic liver diseaseThomas W. Smith, Ari Goldberg, Amy D. Lu
Ann Hepatol. 2021;20C:118
219
Open access
215
Laparoscopic repair of transected right hepatic artery during cholecystectomy: A report of two casesWu Bao-Qiang, Hu Jun, Liu Wen-Song, Jiang Yong, Chen Xue-Min, Sun Dong-Lin
Ann Hepatol. 2021;21C:161
215
Open access
210
Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendationsCarolina Delgado Martínez, Mariano Gómez-Rubio, Cecilia Gómez-Domínguez
Ann Hepatol. 2021;21C:225
210
Open access
185
Liver disease and outcomes among COVID-19 hospitalized patients – A systematic review and meta-analysisAshish Sharma, Pragya Jaiswal, Yasameen Kerakhan, Lakshmi Saravanan, Zeba Murtaza, Azka Zergham, Nagaraj-Sanchitha Honganur, Aelia Akbar, Aran Deol, Benedict Francis, Shakumar Patel, Deep Mehta, Richa Jaiswal, Jagmeet Singh, Urvish Patel, Preeti Malik
Ann Hepatol. 2021;21C:273
185
Open access
Open Article
185
Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver diseaseHumberto O. Galizzi, Claudia A. Couto, Daniela O.L. Taranto, Samuel I.O. Araújo, Eduardo G. Vilela
Ann Hepatol. 2021;20C:229
185
Open access
179
miRNA-338-3p/CAMK IIα signaling pathway prevents acetaminophen-induced acute liver inflammation in vivoChen Zhang, Li Kang, Haihui Zhu, Jing Li, Rong Fang
Ann Hepatol. 2021;21C:191
179
Open access
179
A fat containing combined neuroendocrine carcinoma and hepatocellular carcinoma in the liver: A case reportAtsuyuki Ikeda, Kentaro Aoki, Tsuyoshi Terashima, Yoshio Itokawa, Hiroyuki Kokuryu
179
Open access
Special content about COVID-19
Publish in
Annals of Hepatology
Affiliated societies
